Time for a comprehensive EU strategy for health innovation? Brexit, austerity, ageing and more could disrupt healthcare R&D in Europe. At a Science|Business Network dinner, guests debated what could be done about it 07 Dec 2017 More news about AstraZeneca and Pfizer